Article Figures & Data
Tables
AFTER HODGKIN LYMPHOMA AND ACUTE LYMPHOBLASTIC OR MYELOGENOUS LEUKEMIA5,30,33,36 Risks
Subsequent neoplasms and recurrence
Cardiac disease (after chest radiation)
Oral cancer, osteonecrosis (after azathioprine or radiation to the jaw)
Osteoporosis
Chronic pain, peripheral neuropathy, Raynaud phenomenon
Pulmonary fibrosis, interstitial pneumonitis (after mediastinal radiation and high doses of bleomycin)
Cataracts (after high doses of radiation to head)
Bladder fibrosis, hemorrhagic cystitis, impaired kidney function, bladder cancer (after abdominal radiation)
Esophageal strictures, gastroesophageal reflux disease, enterocolitis, bowel obstruction
InfectionsEducate on sun exposure, signs of cancer, healthy high-fiber diet, avoidance of alcohol, smoking cessation, hand-washing, vaccination, avoidance of people with colds, need to report symptoms Screen
For skin cancer every year
Mammography every 2 years for women age 50 to 7437
Colonoscopy every 5 years after age 35, or 10 years after abdominal radiation
Echocardiography at baseline and periodically
Annual liver screening with aspartate aminotransferase, alanine aminotransferase, and bilirubin for patients who received ≥ 3,000 cGy to upper abdomen, or received methotrexate, mercaptopurine, or thioguanine
Dual-energy x-ray absorptiometry per World Health Organization recommendationsVaccinate against pneumococcus (PCV 13 for immunocompromised individuals),38 influenza (inactivated); live-attenuated virus vaccines (eg, herpes zoster, influenza) can be used with caution and in close contacts of cancer survivors; consider prompt antibiotics to cover gram-positive organisms in those with hypogammaglobulinemia, compromised immunity Monitor for relapse: computed tomography (CT) to evaluate response, then chest radiography or CT every 6 to 12 months for 2 to 5 years Specialist evaluation as appropriate FOR OLDER PATIENTS with chronic lymphocytic leukemia, acute myelogenous leukemia, multiple myeloma and non-Hodgkin lymphoma22,39 Risks
Early onset of diabetes (secondary to steroid use), hypertension (secondary to chemotherapy), osteoporosis (especially after multiple myeloma), cataracts (from steroids), and cardiovascular disease (especially with anthracycline and alkylating agent chemotherapy); reinforce healthy lifestyle, proper screeningAFTER ALL CANCERS33,34 Address educational issues, emotional issues, financial issues, chronic pain, cognitive function, sleep disorders, immunizations, and healthy lifestyle (smoking cessation, weight management, diet, exercise) Cardiovascular risk-factor assessment Immune system
If on chronic graft-vs-host disease prevention: gram-positive encapsulated organism prophylaxis, Pneumocystis carinii pneumonia prophylaxis, cytomegalovirus testing
Revaccinate after stem cell transplant, yearly inactivated influenza vaccineOcular clinical symptom evaluation, ocular fundus examination if previously abnormal Dental assessment Pulmonary
Clinical pulmonary assessment
Smoking avoidance counseling
Pulmonary function testing if previously abnormal
Chest radiography if previously abnormalLiver
Liver enzyme testing if previously abnormal
Serum ferritin testing if previously abnormalKidney
Blood pressure screening
Urine protein screening
Blood urea nitrogen and creatinine testingMuscle and connective tissue
Evaluate for muscle weakness if on chronic graft-vs-host disease prevention
Physical activity counseling and routine exerciseBone and spine
Bone density testing (adult women, all allogeneic transplant recipients and patients at high risk for bone loss), reassess if previously abnormalNervous system
Clinical neurologic evaluation
Evaluate for cognitive developmentEndocrine system
Thyroid function testing
Growth velocity in children
Gonadal function assessment in prepubertal children and in adults if previously abnormalSkin self-examination and sun exposure counseling Gynecologic examination Secondary cancers
Vigilance counseling and screeningPsychosocial, financial, and quality-of-life clinical assessment, sexual function assessment Based on information in references 30 and 32